الفهرس 
Introduction & Aim of the workOnly 14 pages are availabe for public view
 |  | from | 117 |  |  |
| | | from | 117 | | |
Abstract
In 2019, 1.1 billion of the world’s 1.9 billion Women of Reproductive Age (15-49 years) have a need for family planning, with 842 million using contraception and 270 million having an unmet need for contraception.
There are numerous methods for family planning that may be adjusted to the abilities and needs of the individuals involved. Essentially, both partners must be interested in spacing or limiting children, and we must consider the user’s motivation, culture, financial situation, and general health, as well as the individual’s acceptance and desire, while picking a contraceptive approach. There are numerous methods of contraception available, such as oral contraceptive pills, intrauterine devices, condoms, and vaginal diaphream.
The intrauterine device (IUD) is a long-acting, reversible, and effective kind of contraception that is coitus-independent and does not help prevent sexually transmitted diseases.
The intrauterine device is the most widely used contraceptive procedure, with roughly 160 million users worldwide. the most prevalent Contraception used by 14.3% of females using contraception worldwide, is the IUD. IUDs are equally as effective as tubal sterilization. There are the well-known concerns, such as increased menstrual bleeding and pain, but long-term discontinuation rates are normally low.
Due to its superior efficacy and longer duration of effect, the copper IUD is currently the first choice for most women who require intermediate to long-term contraception; however, women with heavy menstruation, dysmenorrhea, anemia, or bleeding dyscrasias prefer using a levonorgestrel-releasing IUD (Mirena), which does not increase menstrual blood loss or cramping.
The Levonorgestrel releasing intrauterine device (Mirena), according to Dr. Cross, helps to prevent conception by releasing levonorgestrel, which inhibits your ovaries from generating an egg every month. The female will ovulate properly but the copper intrauterine device does not utilize hormones. The copper on the IUD, on the other hand, creates an adverse environment for sperm, making it more difficult for the sperm to reach the egg in the fallopian tubes and so prevent conception.
The insertion of an intrauterine device (IUD) is a common procedure in clinics and surgeries. Inserting a levonorgestrel-releasing intrauterine device (Mirena) was more challenging and was associated with more device difficulties and adverse reactions than inserting a copper intrauterine device.
The failure rate of both kinds of intrauterine devices is minimal. In contrast, the mirena (levonorgestral releasing intrauterine device) was associated with a lower risk of pregnancy, including ectopic pregnancy, than the copper intrauterine device.
The purpose of this study is to see whether Egyptian women are willing to use the levonorgestrel IUD (Mirena).
This research was carried out in the Minia and Maghaghuh clinics, where 500 women used the levonorgestrel IUD (Mirena) for contraception.
The main results of the study revealed that:
The average age is 28.56 7.49 years old, with a BMI of 26.71 kg/m2. Meanwhile, 54.2% of patients were rural, and 45.8% were urban.
Patients were 38.4% housewives, 21.6% teachers, 14.2% secretaries, 4.2% doctors, and 11.8% students.
37.2% had finished secondary school, 29.4% had finished elementary school, and 25% had finished higher education. In addition, 8.4% of the population was illiterate.
38.4% of patients were aware of the levonorgestrel IUD, with 31.6% having previous knowledge. A physician was the most common source (15.6%). As a type of contraception, 25.6% of patients consent to use a levonorgestrel IUD.
21.1% expected PID, 42.2% expected increased bleeding during menstruation, 19.5% expected Mirena to interfere with sexual relations, 13.3% expected Mirena to interfere with ability to conceive after removal, and 28.1% expected Mirena to change its position after insertion.
89.1% of persons who used a levonorgestrel IUD were satisfied with it. Concerning issues, 14.8% reported increased bleeding after insertion, 11.7% reported pain during menstruation after insertion, and 2.3% reported PID.
Furthermore, 78.9% want to continue using the levonorgestrel IUD (Mirena) and 71.1% intend to promote it to friends.
Conclusion
The usage of levonorgestrel IUD (Mirena) is low in our environment, and the rate of withdrawal due to unpleasant effects is high.
To increase uptake and reduce discontinuation rates due to side effects, it is necessary to dispel misconceptions about it and educate clinicians on the need of counseling.
In a prospective study, a larger sample size would provide more information on acceptance, cessation, and potential solutions.
Additional study on availability, accessibility, and customer knowledge assessment may also be undertaken.